AI Summary
Thinking
Thinking
We reviewed 35 live results for adalimumab and narrowed them down to the 3 options that look most worth comparing first.
The options are Adalimumab, Adalimumab and Idacio (adalimumab).
Source: Humira
Description
A potent biologic immunomodulator and TNF inhibitor used for the management of chronic autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Available in Thailand through specialized hospital pharmacies, this treatment helps regulate the immune system's inflammatory response.
Best for
rheumatoid arthritis patients, Crohn's disease management, chronic inflammation and autoimmune conditions
Rate this product
Source: Bumrungrad International Hospital
Description
A biologic DMARD and TNF inhibitor used for patients with moderate to severe rheumatoid arthritis. Available as sterile solutions for injection (40 mg or 20 mg), it is often reserved for those who do not respond to conventional treatments.
Best for
advanced RA treatment, TNF inhibitor therapy, biologic DMARD access and patients failing conventional therapy
Rate this product
Source: Fresenius Kabi
Description
Idacio is a biosimilar biologic medication containing adalimumab, a TNF-alpha inhibitor used to treat a wide range of inflammatory conditions. These include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The medication is typically provided as a 40 mg/0.8 mL solution for subcutaneous injection, available in formats such as a single-dose pre-filled pen (autoinjector), a pre-filled syringe, or a single-dose vial for pediatric or specific dosing needs. As a biosimilar, it offers a clinically equivalent and often more accessible alternative to the reference product Humira.
Best for
rheumatoid arthritis treatment, psoriasis management, Crohn’s disease patients, biosimilar medication seekers and subcutaneous injection therapy
Rate this product
| Compare | #1Adalimumab | #2Adalimumab | #3Idacio (adalimumab) |
|---|---|---|---|
| Source | Humira | Bumrungrad International Hospital | Fresenius Kabi |
| Description | A potent biologic immunomodulator and TNF inhibitor used for the management of chronic autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Available in Thailand through specialized hospital pharmacies, this treatment helps regulate the immune system's inflammatory response. | A biologic DMARD and TNF inhibitor used for patients with moderate to severe rheumatoid arthritis. Available as sterile solutions for injection (40 mg or 20 mg), it is often reserved for those who do not respond to conventional treatments. | Idacio is a biosimilar biologic medication containing adalimumab, a TNF-alpha inhibitor used to treat a wide range of inflammatory conditions. These include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The medication is typically provided as a 40 mg/0.8 mL solution for subcutaneous injection, available in formats such as a single-dose pre-filled pen (autoinjector), a pre-filled syringe, or a single-dose vial for pediatric or specific dosing needs. As a biosimilar, it offers a clinically equivalent and often more accessible alternative to the reference product Humira. |
| Best for | rheumatoid arthritis patients, Crohn's disease management, chronic inflammation and autoimmune conditions | advanced RA treatment, TNF inhibitor therapy, biologic DMARD access and patients failing conventional therapy | rheumatoid arthritis treatment, psoriasis management, Crohn’s disease patients, biosimilar medication seekers and subcutaneous injection therapy |
| Action | Humira | Bumrungrad International Hospital | Fresenius Kabi |
| Rate this product |
"Adalimumab from Humira."
TopFind picked this because a globally recognized biologic treatment for managing serious autoimmune and inflammatory conditions.
Note: TopFind AI compiles product and service information for general comparison purposes only.